期刊文献+

激素治疗溃疡性结肠炎黏膜愈合程度与预后的关系 被引量:3

The relationship between mucosal healing and outcomes in ulcerative colitis after treatment with corticosteroids
下载PDF
导出
摘要 目的探讨激素治疗溃疡性结肠炎(UC)的黏膜愈合程度与其预后的相关性。方法对接受激素治疗(n=86)的UC患者随访2年。首先在治疗6个月后对其进行早期临床疗效评价(Powel-Tuck,PT)和组织病理学分级,并将患者分为完全应答(A组:PT,0~1分;病理分级,0级)、部分应答(B组:PT,0~1分;病理分级,Ⅰ~Ⅱ级)和无应答(C组:PT≥2分;病理分级≥Ⅲ级)。随后对其疾病复发、再入院、结肠手术、免疫抑制剂使用等预后情况进行追踪,评估早期治疗UC的黏膜愈合程度和其后期预后的相关性。结果 2年后,完全(A组)和部分应答(B组)患者预后情况在以下方面出现差异:再入院率[A组27.5%vs B组44.1%;P=0.018;OR=2.24;95%CI(1.11~3.98)]、免疫抑制治疗[A组7.5%vs B组26.5%;P=0.008;OR=5.67;95%CI(3.24~8.93)]、结肠切除术[A组0.00%vs B组17.6%;P=0.035;OR=5.43;95%CI(2.14~7.64)]。结论激素治疗UC早期达到黏膜愈合与其后期良好的预后存在明显的正相关。 Objective To evaluate the relationship between mucosal healing and outcomes in ulcerative colitis (UC) after treatment with corticosteroids. Methods Patients with UC who were prescribed corticosteroid therapy (n = 86) were followed up for 2 years. They were evaluated by clinical (Powel-Tuck, PT) and histopathology grading after 6 months, outcomes at 6 months ( early response) were used to identify patients with complete ( group A : PT, 0 - 1 ; his- topathology grading, 0) , partial ( group B : PT, 0 - 1 ; histopathology grading, Ⅰ-Ⅱ) , or no response (group C : PT 2 ; histopathology grading≥Ⅲ ). The association between mucosal healing and late outcomes was assessed. Results After 2 years, there were significant differences between complete and partial responders in the rates of hospitalization [ 27.5 % in group A vs 44.1% in group B ; P = 0.018 ; OR = 2.24 ;95 % CI ( 1.11 - 3.98 ) ], immunosuppression therapy [(7.5% in group A vs26.5% in group B; P=0.008; OR=5.67;95%CI(3.24-8.93)] , coleetomy [0.00% in group A vs 17.6% in group B ; P = 0. 035 ; OR = 5.43 ;95% CI(2.14 - 7.64) ]. Conclusion Mucosal healing after corticosteroid therapy is associated with late outcomes in UC.
出处 《胃肠病学和肝病学杂志》 CAS 2013年第3期246-249,共4页 Chinese Journal of Gastroenterology and Hepatology
基金 佛山市卫生局立项(2012054)
关键词 溃疡性结肠炎 黏膜愈合 预后 激素 Ulcerative colitis Mucosal healing Outcomes Corticosteroid
  • 相关文献

参考文献16

  • 1Kornbluth A, Sachar DB, Ulcerative colitis practice guidelines in a- dults: American College of Gastroenterology, Practice Parameters Com- mittee [J]. Am J Gastroenterol, 2010, 105(3) : 501-524.
  • 2Bianehi PG, Cassinotti A, Ferrara E, et al. Review article: the man- agement of steroid dependency in ulcerative colitis [ J]. Aliment Phar- maeol Ther, 2007, 26(6) : 779-794.
  • 3Rutgeerts PS, Vermeire G. Van Assehe G, et al. Mueosal healing in inflammatory bowel disease: impossible ideal or therapeutic target? [J]. Gut, 2007, 56(4):453-455.
  • 4William A, Faubion JR, Edward V, et al. The natural history of eorti- costeroid therapy for inflammatory bowel disease: a population-based study [ J ]. Gastroenterology, 2001, 121 (2) : 255-260.
  • 5GT HO, Chiam P, Drummond H, et al. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK incep- tion cohort [ J ]. Aliment Pharmacol Ther. 2006, 24 (2) : 319-330.
  • 6中华医学会消化病学分会炎症性肠病协作组,欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见(2007年,济南)[J].中华消化杂志,2007,27(8):545-550. 被引量:1024
  • 7Kornbluth A, Sachar DB, Practice Parameters Committee of the Ameri- can College of Gastroenterology. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Pa- rameters Committee [ J ]. Am J Gastroenterol, 2004, 99 ( 24 ) :1371-1385.
  • 8钟英强,朱兆华,幸连春,陈其奎,占俊,李楚强.活动期溃疡性结肠炎活检黏膜的组织学分级与临床分级和内镜分级的关系[J].中华消化内镜杂志,2003,20(4):249-252. 被引量:47
  • 9Ardizzone S, Cassinotti A, Duca P, et al. Mucosal healing predicts late outcomes after the first course of corticosteroids for newly diagnosed ulcerative colitis [ J ]. Clin Gastroenterol Hepatol, 2011, 9 ( 6 ) : 483--489.
  • 10黄红丽,聂玉强,李瑜元.溃疡性结肠炎临床严重度分型与内镜、病理分级的关系[J].现代消化及介入诊疗,2008,13(2):79-81. 被引量:25

二级参考文献33

  • 1夏冰,周燕.炎症性肠病的内镜活检诊断问题[J].中华消化内镜杂志,1996,13(2X):276-278. 被引量:8
  • 2[2]Kombluth A,Sachar DB; Practice Parameters Committee of the American College of Gastroenterology.Ulcerative colitis practice guidelines in adults (update):American College of Gastroenterology,Practice Parameters Committee.Am J Gastroenterol 2004; 99:1371-1385.
  • 3[4]Pullan RD,Rhodes J,Ganesh S,et al.Tansdermal nicotine for active ulcerative colitis.N Engl J Med 1994;330:811-815.
  • 4[5]Mutinga ML,Odze RD,Wang HH,et al.The clinical significance of right-sided colonic inflammation in patients with left-sided chronic ulcerative colitis.Inflamm Bowel Dis 2004;10:215-219.
  • 5[6]Silverberg MS,Satsangi J,Abroad T,et al.Toward an integrated clinical,molecular and serological classification of inflammatory bowel disease:Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.Can J Gastroenterol 2005;19(Suppl A):5-36.
  • 6[7]Tanaka M,Kusumi T,Oshitani N,et al.Validity of simple mucosal biopsy criteria combined with endoscopy predicting patients with ulcerative colitis ultimately requiting surgery:a multicenter study.Scand J Gastroenterol 2003;38:594-598.
  • 7[8]Winther KV,Jess T,Langholz E,et al.Survival and cause-spocific mortality in ulcerative colitis:follow-up of a population-based cohort in Copenhagen County.Gastroenterology 2003;125:1576-1582.
  • 8[9]Bitton A,Peppercorn MA,Antonioli DA,et al.Clinical,biological and histologic parameters as predictors of relapse in ulcerative colitis.Gastroenterology 2001;120:13-20.
  • 9Pullan RD, Rhodes J, Ganosh S ,et al. Tansdermal nicotine for active ulcerative colitis. New Engl J Med,1994,330: 811-815.
  • 10Seo M, Kada M, Yao T, et al. An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol, 1992, 87:971-976.

共引文献1085

同被引文献23

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部